← Back to headlines
Moderna's mRNA Cancer Treatment Shows Promise, Boosting Share Price
Moderna's stock has nearly tripled after its mRNA cancer treatment showed promising results, bringing back memories of the company's pandemic-era surge following years of struggle.
20 Aug, 15:13 — 20 Aug, 15:13
Sources
Showing 1 of 1 sources
Related Stories
Nvidia Reports Record Second-Quarter Earnings Driven by Surging AI Demand
41m ago
Universal Studios Japan Announces Nearly $2 Billion Expansion Project
1h ago
Nvidia Earnings Fuel Broad Market Rally Ahead of Jackson Hole Symposium
1h ago
Mixed Corporate Earnings Drive Market Movements as Burlington Slides
1h ago